Hi there,

Democracy Now is committed to bringing you the stories and perspectives you won't hear anywhere else, from the peace activists demanding an end to war to Indigenous leaders fighting to stop fossil fuel extraction and save the planet. Our independent reporting is only possible because we’re funded by you—not by the weapons manufacturers when we cover war or gun violence, not by the oil, gas, coal, or nuclear companies when we cover the climate crisis. Can you donate $10 today to keep us going strong? Every dollar makes a difference. Right now a generous donor will DOUBLE your donation, making it twice as valuable to Democracy Now! Please do your part today, and thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

New Study Finds Hydroxychloroquine Does Not Help COVID-19, Can Cause Heart Attacks

HeadlineMay 12, 2020

The largest study to date on the use of hydroxychloroquine against the coronavirus has confirmed earlier research that the anti-malarial drug could cause serious heart problems and is not an effective treatment for COVID-19. Trump has repeatedly touted the drug. The latest study — published Monday in the Journal of the American Medical Association — looked at nearly 1,500 patients in New York and found that those on hydroxychloroquine had a similar death rate to those who did not take it, but were more than twice as likely to suffer cardiac arrest. Dr. William Schaffner, an infectious disease expert and adviser to the Centers for Disease Control and Prevention, said, “The nail has virtually been put in the coffin of hydroxychloroquine.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top